324 related articles for article (PubMed ID: 12151113)
1. Critical re-evaluation of previous preclinical strategies for the discovery and the development of new antiepileptic drugs.
Löscher W; Leppik IE
Epilepsy Res; 2002 Jun; 50(1-2):17-20. PubMed ID: 12151113
[TBL] [Abstract][Full Text] [Related]
2. New strategies for the identification of drugs to prevent the development or progression of epilepsy.
Schmidt D; Rogawski MA
Epilepsy Res; 2002 Jun; 50(1-2):71-8. PubMed ID: 12151119
[TBL] [Abstract][Full Text] [Related]
3. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs.
Löscher W
Seizure; 2011 Jun; 20(5):359-68. PubMed ID: 21292505
[TBL] [Abstract][Full Text] [Related]
4. [The new antiepileptic drugs: their indications and side effects].
Malagón-Valdez J
Rev Neurol; 2004 Sep 16-30; 39(6):570-5. PubMed ID: 15467997
[TBL] [Abstract][Full Text] [Related]
5. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma.
Löscher W; Schmidt D
Epilepsia; 2011 Apr; 52(4):657-78. PubMed ID: 21426333
[TBL] [Abstract][Full Text] [Related]
6. Key factors in the discovery and development of new antiepileptic drugs.
Bialer M; White HS
Nat Rev Drug Discov; 2010 Jan; 9(1):68-82. PubMed ID: 20043029
[TBL] [Abstract][Full Text] [Related]
7. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
Klitgaard H; Matagne A; Nicolas JM; Gillard M; Lamberty Y; De Ryck M; Kaminski RM; Leclercq K; Niespodziany I; Wolff C; Wood M; Hannestad J; Kervyn S; Kenda B
Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
[TBL] [Abstract][Full Text] [Related]
8. Zurich Consensus Conference on New Antiepileptic Drugs. Introduction: goals.
Wieser HG
Epilepsia; 1994; 35 Suppl 5():S1-5. PubMed ID: 8039463
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy.
Campos G; Fortuna A; Falcão A; Alves G
Epilepsy Res; 2018 Oct; 146():63-86. PubMed ID: 30086482
[TBL] [Abstract][Full Text] [Related]
10. The pharmacologic basis of antiepileptic drug action.
Rho JM; Sankar R
Epilepsia; 1999 Nov; 40(11):1471-83. PubMed ID: 10565572
[TBL] [Abstract][Full Text] [Related]
11. Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX).
Bialer M; Johannessen SI; Levy RH; Perucca E; Tomson T; White HS
Epilepsy Res; 2009 Jan; 83(1):1-43. PubMed ID: 19008076
[TBL] [Abstract][Full Text] [Related]
12. The clinical impact of new antiepileptic drugs after a decade of use in epilepsy.
Schmidt D
Epilepsy Res; 2002 Jun; 50(1-2):21-32. PubMed ID: 12151114
[TBL] [Abstract][Full Text] [Related]
13. Development of new antiepileptic drugs: challenges, incentives, and recent advances.
Perucca E; French J; Bialer M
Lancet Neurol; 2007 Sep; 6(9):793-804. PubMed ID: 17706563
[TBL] [Abstract][Full Text] [Related]
14. Finding a better drug for epilepsy: preclinical screening strategies and experimental trial design.
Simonato M; Löscher W; Cole AJ; Dudek FE; Engel J; Kaminski RM; Loeb JA; Scharfman H; Staley KJ; Velíšek L; Klitgaard H
Epilepsia; 2012 Nov; 53(11):1860-7. PubMed ID: 22708847
[TBL] [Abstract][Full Text] [Related]
15. Strategies for the development of drugs for pharmacoresistant epilepsies.
Heinemann U; Draguhn A; Ficker E; Stabel J; Zhang CL
Epilepsia; 1994; 35 Suppl 5():S10-21. PubMed ID: 7518767
[TBL] [Abstract][Full Text] [Related]
16. What new modeling approaches will help us identify promising drug treatments?
Baraban SC; Löscher W
Adv Exp Med Biol; 2014; 813():283-94. PubMed ID: 25012385
[TBL] [Abstract][Full Text] [Related]
17. Innovations in epilepsy management - an overview.
Abraham S; Shaju M
J Pharm Pharm Sci; 2013; 16(4):564-76. PubMed ID: 24210064
[TBL] [Abstract][Full Text] [Related]
18. Challenges in the clinical development of new antiepileptic drugs.
Franco V; French JA; Perucca E
Pharmacol Res; 2016 Jan; 103():95-104. PubMed ID: 26611249
[TBL] [Abstract][Full Text] [Related]
19. The interface of preclinical evaluation with clinical testing of antiepileptic drugs: role of pharmacogenomics and pharmacogenetics.
Holmes GL
Epilepsy Res; 2002 Jun; 50(1-2):41-54. PubMed ID: 12151116
[TBL] [Abstract][Full Text] [Related]
20. Chemical properties of antiepileptic drugs (AEDs).
Bialer M
Adv Drug Deliv Rev; 2012 Jul; 64(10):887-95. PubMed ID: 22210279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
